C 
CVS Health CVS · USD
Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States
S&P 500
85.25
+1.67%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$402.07bn
FY2016FY2025
Net income
$1.77bn
FY2016FY2025
Free cash flow
$7.81bn
FY2016FY2025
Shareholders' equity
$75.21bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $402.07bn | $372.81bn | $357.78bn | $322.47bn | $292.11bn | $268.71bn | $256.78bn | $194.58bn | $184.79bn | $177.55bn |
| Gross profit | $55.36bn | $51.40bn | $54.43bn | $54.50bn | $52.12bn | $49.05bn | $45.53bn | $31.54bn | $28.53bn | $28.83bn |
| Operating income | $5.25bn | $8.52bn | $13.74bn | $7.95bn | $13.31bn | $12.68bn | $12.03bn | $4.02bn | $9.54bn | $9.71bn |
| Net income | $1.77bn | $4.61bn | $8.34bn | $4.31bn | $8.00bn | $7.18bn | $6.63bn | −$594.0m | $6.62bn | $5.32bn |
| Diluted earnings per share | 1.38 | 3.66 | 6.45 | 3.27 | 5.99 | 5.45 | 5.06 | -0.53 | 6.50 | 4.97 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $261.06bn | $253.22bn | $249.73bn | $228.28bn | $233.00bn | $230.72bn | $222.45bn | $196.46bn | $95.13bn | $94.46bn |
| Cash and short-term investments | $10.66bn | $10.99bn | $11.46bn | $15.72bn | $12.53bn | $10.85bn | $8.06bn | $6.58bn | $1.81bn | $3.46bn |
| Total liabilities | $185.68bn | $177.49bn | $173.09bn | $156.51bn | $157.62bn | $161.01bn | $158.28bn | $137.91bn | $57.44bn | $57.63bn |
| Debt | $64.57bn | $66.27bn | $61.61bn | $52.25bn | $56.18bn | $64.65bn | $68.48bn | $73.43bn | $27.00bn | $27.53bn |
| Shareholders' equity | $75.21bn | $75.56bn | $76.46bn | $71.47bn | $75.08bn | $69.39bn | $63.86bn | $58.23bn | $37.69bn | $36.83bn |
| Shares outstanding | 1,277m | 1,261m | 1,293m | 1,319m | 1,336m | 1,317m | 1,310m | 1,121m | 1,018m | 1,069m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $10.64bn | $9.11bn | $13.43bn | $16.18bn | $18.27bn | $15.87bn | $12.85bn | $8.87bn | $8.01bn | $10.14bn |
| Capital spending | −$2.83bn | −$2.78bn | −$3.03bn | −$2.73bn | −$2.52bn | −$2.44bn | −$2.46bn | −$2.04bn | −$1.92bn | −$2.22bn |
| Free cash flow | $7.81bn | $6.33bn | $10.39bn | $13.45bn | $15.74bn | $13.43bn | $10.39bn | $6.83bn | $6.09bn | $7.92bn |
| Dividends paid | −$3.40bn | −$3.37bn | −$3.13bn | −$2.91bn | −$2.63bn | −$2.62bn | −$2.60bn | −$2.04bn | −$2.05bn | −$1.84bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $106.10bn | $100.43bn | $105.69bn | $102.87bn | $98.92bn | $94.59bn | $97.71bn | $95.43bn |
| Gross profit | $15.75bn | $15.62bn | $13.57bn | $13.81bn | $13.59bn | $14.40bn | $12.90bn | $12.56bn |
| Operating income | $4.70bn | $4.68bn | $2.11bn | −$3.21bn | $2.38bn | $3.37bn | $2.37bn | $832.0m |
| Net income | $3.00bn | $2.94bn | $2.94bn | −$3.98bn | $1.02bn | $1.78bn | $1.64bn | $87.0m |
| Diluted earnings per share | 2.33 | 2.29 | 2.30 | -3.11 | 0.80 | 1.39 | 1.30 | 0.07 |
| Cash from operations | $6.34bn | $4.25bn | $3.39bn | $796.0m | $1.90bn | $4.56bn | $1.86bn | −$745.0m |
| Capital spending | −$691.0m | −$849.0m | −$784.0m | −$698.0m | −$607.0m | −$743.0m | −$768.0m | −$670.0m |
| Free cash flow | $5.65bn | $3.40bn | $2.61bn | $98.0m | $1.29bn | $3.81bn | $1.09bn | −$1.42bn |
| Total assets | $253.77bn | $252.97bn | $261.06bn | $255.33bn | $258.34bn | $255.59bn | $253.22bn | $252.43bn |
| Cash and short-term investments | $13.96bn | $11.80bn | $10.66bn | $11.29bn | $14.22bn | $12.65bn | $10.99bn | $9.68bn |
| Debt | $63.32bn | $65.02bn | $66.31bn | $67.75bn | $68.40bn | $66.62bn | $68.02bn | $67.45bn |
| Shareholders' equity | $79.70bn | $77.46bn | $75.21bn | $72.93bn | $77.38bn | $76.93bn | $75.56bn | $74.94bn |
Financial ratios
Data as of 10 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 13.8% | 13.8% | 15.2% | 16.9% | 17.8% | 18.3% |
| Operating margin | 1.3% | 2.3% | 3.8% | 2.5% | 4.6% | 4.7% |
| Net margin | 0.4% | 1.2% | 2.3% | 1.3% | 2.7% | 2.7% |
| Return on equity | 2.4% | 6.1% | 10.9% | 6.0% | 10.7% | 10.3% |
| Return on assets | 0.7% | 1.8% | 3.3% | 1.9% | 3.4% | 3.1% |
| Free cash flow yield | 11.1% | 9.9% | 13.3% | 15.0% | 16.3% | 14.6% |
| Revenue growth | 7.8% | 4.2% | 10.9% | 10.4% | 8.7% | 4.6% |
| Earnings growth | -61.7% | -44.7% | 93.6% | -46.1% | 11.5% | 8.2% |
| Current ratio | 0.84x | 0.81x | 0.86x | 0.95x | 0.88x | 0.91x |
| Debt to equity | 0.88x | 0.90x | 0.83x | 0.75x | 0.77x | 0.96x |
| Equity ratio | 28.8% | 29.8% | 30.6% | 31.3% | 32.2% | 30.1% |
| Interest coverage | 1.68x | 2.88x | 5.17x | 3.48x | 5.32x | 4.36x |
| Buybacks as a share of market value | -1.3% | 2.5% | 2.0% | 1.3% | -1.4% | -0.5% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 7.6% | 8.4% | 10.1% |
| Operating income | -12.9% | -16.1% | -5.7% |
| Net income | -25.7% | -24.4% | -10.3% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 13.8% | 14.8% | 15.7% | 16.0% |
| Operating margin | 1.8% | 2.4% | 3.0% | 3.6% |
| Net margin | 0.8% | 1.3% | 1.7% | 1.9% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 57.3 | 12.3 | 12.2 | 28.5 | 17.2 | 12.5 | 14.7 | -123.7 | 11.2 | 15.9 |
| Price to sales | 0.3 | 0.1 | 0.3 | 0.4 | 0.5 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 |
Market value over time
31 Oct 2016 to 9 Sept 2026, in USD
$90.24bn$122.37bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 72% | -41% | -20% | -5% | 46% | -8% | 12% | -10% | -8% | -17% |
Dividends and splits
Per share, in the currency the company pays
Paid for 36 years. Last went ex-dividend on 23 Jul 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 1.995 | 2.66 | 1.995 | 2.48 | 2.255 | 2.55 | 2.00 | 2.00 |
- 2-for-1 split · 7 Jun 2005
- 2-for-1 split · 16 Jun 1998
- 2-for-1 split · 15 Mar 1989
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.